Gene Query: COL17A1

Dataset Description Geneva Score
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 205.54
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 146.42
MCF10A H-Ras RNA-Seq 136.37
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 123.53
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 107.39
Ectoderm specification of H1 human embryonic stem cells 105.61
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 91.33
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 91.33
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 79.48
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 78.42
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 77.28
IRF1 regulates IFN dependent and independent gene expression 75.48
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 73.58
WRN knockout effects upon gene expression in SW48 and OVK18 73.25
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 73.05
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 73.05
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 72.93
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 72.93
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 72.93
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 70.3
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 70.3
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 65.44
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 63.93
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 62.99
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 62.6
Generation of KRAS signatures using immortalized isogenic lung cells. 62.03
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 61.59
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 60.72
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 57.89
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 57.12
Lipid degradation promotes prostate cancer cell survival 56.5
Transcriptome profiling of Normal and Cancerous Prostate Cells 54.23
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 54.02
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 52.87
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 52.56
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 52.56
Differential Gene Expression between MCF10A and MCF7 cells 52.55
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 51.74
Effect of BMP inhibition or stimulation of primary human keratinocytes 48.47
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 48.47
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 47.17
A prostate cancer chromatin interaction map 47.06
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 46.3
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 45.08
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 43.92
Fbxo32 mediated gene expression program underlies EMT and metastasis 43.41
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 42.88
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 41.74
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 41.66
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 41.14
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 41.03
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 40.86
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 39.72
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 39.72
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 39.34
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 39.34
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 38.02
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 37.01
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 36.48
circRNA profile in hypopharyngeal cancer 34.33
circNFIB suppresses lymphatic metastasis of pancreatic cancer 33.78
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 33.74
RNA m5C Methylation in breast cancer using MeRIP-Seq 33.43
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 32.88
RNA-seq of MCF10A cells and CAF 32.49
Transcriptomic and gene ontology profiling of the human corneal cell types 32.33
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 31.86
Expression profiling of converted and control dermal BJ fibroblasts 31.86
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 31.85
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 31.12
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 31.05
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 29.77
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 29.58
Gene expression profile of human placenta from T. Cruzi infected mothers 28.23
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 28.12
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 27.64
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 27.53
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 27.52
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 27.49
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 27.2
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 26.55
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 26.49
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 26.45
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 25.89
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 25.89
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 25.54
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 25.42
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 25.06
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 24.92
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 24.25
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 24.25
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 24.19
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 23.35
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 23.35
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 23.11
Transcriptome of U251 cells overexpression complement component 7 23.08
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 23.03
The Genomic Landscape of Atypical Fibroxanthoma 22.56
Gene expression alterations of pancreatic intraepithlial neoplasia 22.08
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 21.44
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 20.71
Dermal endothelial cells of type 2 diabetic patients 20.48
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 20.31
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 20.22
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 20.22
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 20.06
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 19.94
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 19.47
CSL RNA-Seq on HKC and SCC cell lines 18.84
CSL 18.84
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 18.83
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 18.76
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 18.76
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 18.4
H1609088 Human RNA-Sequencing 18.15
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 18.1
Epigenome regulation during epidermal lineage commitment 17.58
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 17.47
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 17.02
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 16.99
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 16.8
Human T-cell lymphoblastic lymphoma samples and control thymuses 16.8
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 16.3
Fusion discovery in breast cancer cell line 16.17
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 16.14
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 16.05
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 15.91
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 15.88
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 15.88
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 15.83
A practical evaluation of alignment algorithms for RNA variant calling analysis 15.27
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 14.7
Total RNA sequencing of APC mutant and wt colonic organoids 14.6
Differentially expressed genes post knock down of lincDUSP26 14.35
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 14.04
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 14.04
TGF-β regulation of miRNA expression in pancreatic cancer 13.79
Transcriptome of EBV-infected gastric cancer cell lines 13.41
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 13.3
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 13.3
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 13.26
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 13.22
Epigenome regulation during epidermal lineage commitment [RNA-seq] 13.17
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 12.83
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 12.74
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 12.74
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 12.46
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 12.41
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 12.29
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 12.27
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 12.22
MicroRNA Marker Based Prognostication of Oral Squamous Cell Carcinoma 12.14
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 11.69
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 11.54
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 11.53
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 11.47
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 11.43
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 11.32
Characterization of the Merkel cell carcinoma miRNome 11.31
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 11.29
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 11.28
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 11.25
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 11.18
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 11.07
Controlling for gene expression changes in transcription factor protein networks. 10.93
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 10.9
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 10.84
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 10.75
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 10.61
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 10.45
mRNA-sequencing of breast cancer subtypes and normal tissue 10.41
An siRNA screen identifies CHD4 as a target for epigenetic therapy 10.38
RNA Sequencing of three pairs of gastric cancer 10.19
10.17
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 9.88
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 9.87
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 9.86
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 9.79
A transcriptome dataset revealing the molecular features of breast cancer stem cells 9.77
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 9.7
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 9.7
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 9.7
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 9.7
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 9.6
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 9.57
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 9.56
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 9.53
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 9.44
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 9.41
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 9.41
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 9.36
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 9.36
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 9.21
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 9.21
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 9.17
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 8.98
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 8.94
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 8.91
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 8.71
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 8.7
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 8.61
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 8.36
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 8.22
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 8.16
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 8.05
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 7.95
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 7.91
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 7.71
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 7.66
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 7.61
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 7.59
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 7.55
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 7.53
RNA sequencing of human pancreatic cancer cell lines 7.44
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 7.37
Regulatory network controlling tumor-promoting inflammation in human cancers 7.28
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 7.28
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 7.23
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 7.23
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 7.23
Transcriptional profiling of LS1034 cells treated with tepoxalin 7.22
Transcriptome analysis of human lung epithelial cells 7.14
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 7.04
Hypoxic transcriptome of SQ20B human head and neck cancer cells 6.82
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 6.78
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 6.77
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 6.75
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 6.71
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 6.71
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 6.68
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 6.68
RNA-sequencing of formalin fixed human primary melanoma tissue 6.54
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 6.5
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 6.43
Identifying the molecular mode of action of itraconazole in colorectal cancer 6.4
Identification of long noncoding RNAs regulated by p53 6.33
mRNA sequencing analysis of cultured human primary airway epithelial cells upon exposure to PMN exosomes 6.29
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 6.27
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 6.22
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 6.03
Persistence of stem cell metabolism in cancers as a failure of differentiation 6.0
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 5.97
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 5.97
Differences in miRNA Detection Levels are Technology and Sequence Dependent 5.9
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 5.9
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 5.89
Comparative Transcriptomics of Triple Negative Breast Cancer Stem Cells and Differentiated Tumor Cells Identifies Teneurin-4 as a Potential Therapeutic Target 5.67
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 5.65
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 5.65
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 5.56
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 5.44
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 5.26
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 5.17
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 5.06
The expression profiles of GBC liver metastasis 5.02
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 4.97
RNAseq analysis of ruxolitinib treated breast cancers 4.97
RNA-seq of YB5 cells treated with Proscillaridin A 4.95
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 4.94
Transcriptome profiling of 5 human adenocarcinoma cell lines 4.93
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 4.87
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 4.82
Inhibition of TNBC metastasis by Gpx1 4.8
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 4.7
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 4.7
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 4.63
Total RNA sequencing of WT intestinal orgaonids. 4.58
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 4.58
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 4.53
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 4.49
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 4.48
Investigate A2M treatment on human prostate cancer and mouse liver 4.44
Investigate A2M treatment on human prostate cancer xenograft in mice 4.44
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 4.22
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 4.22
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 4.22
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 4.15
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 4.15
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 4.14
Deep RNA sequencing of the human placental transcriptome 4.14
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 4.11
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 4.06
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 3.98
Transcriptome analysis reveals differential splicing events in IPF lung tissue 3.94
TCF7L1 knockdown in pancreatic cancer 3.92
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 3.9
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 3.86
RNA-seq of IL-4 stimulated human keratinocytes 3.81
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 3.81
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 3.73
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 3.7
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 3.7
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 3.68
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 3.67
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 3.63
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 3.58
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 3.58
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 3.55
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 3.51
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 3.49
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 3.48
RNA seq_PDX2_SHP099 3.46
RNA seq comparison between scrambled and shGRP78 cells 3.41
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 3.38
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 3.37
Transcriptomic profile of human embryonic renal corpuscles 3.36
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 3.32
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 3.29
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 3.28
Gene expression profiling in metabolically heterogeneous human lung tumors 3.28
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 3.27
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 3.26
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 3.26
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 3.25
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 3.24
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 3.24
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 3.15
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 3.13
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 3.12
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 3.12
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 3.09
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 3.08
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 3.05
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 3.01
Transcriptional effect of ETV1 knockdown in melanoma cells 2.96
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 2.95
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 2.94
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 2.93
Electronic cigarettes 2.93
Transcriptomic analysis of LSD1 2.91
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 2.91
Characterization of parental and rociletinib-resistant derived H1975 cell lines 2.88
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 2.84
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 2.83
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 2.83
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 2.81
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 2.8
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 2.77
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 2.77
UBC9 knockdown in bladder cancer T24 cell lines 2.73
Gene expression of collecting duct carcinoma of the kidney 2.72
RNA-seq of SCLC PDX models treated with EP 2.7
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 2.64
Statins modulate endothelial transcriptional profile by inhibiting EZH2 2.64
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 2.61
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 2.61
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 2.59
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 2.58
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 2.58
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 2.57
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 2.57
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 2.57
mRNA sequencing of oropharyngeal cancer cell lines 2.55
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 2.52
Loss of endometrial plasticity in recurrent pregnancy loss 2.4
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 2.4
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 2.4
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 2.38
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 2.36
Overexpression and knockdown experiment for circCSNK1G3 2.36
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 2.35
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 2.31
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 2.31
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 2.29
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 2.29
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 2.29
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 2.25
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 2.21
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 2.17
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 2.17
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 2.1
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 2.03
Endometrial transcriptome and PGR cistrome in cycling fertile women 2.03
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 2.02
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 2.02
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 2.01
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 1.99
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 1.99
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 1.98
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 1.98
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 1.96
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 1.96
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 1.96
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 1.94
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 1.93
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 1.9
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 1.88
MRTF activates TEAD-YAP target gene expression 1.87
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 1.87
Gene expression changes associated with resistance to tagraxofusp (SL-401) 1.85
The role of the Calcium-Sensing receptor in colorectal cancer 1.85
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 1.84
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 1.79
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 1.78
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 1.78
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 1.72
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 1.7
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 1.69
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 1.69
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 1.67
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 1.66
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 1.66
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 1.65
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 1.6
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 1.56
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 1.56
iPSC-Derived Cholangiocytes 1.55
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 1.55
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 1.54
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 1.53
Nonpregnant and term pregnant human myometrial tissues 1.47
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 1.47
Small-molecule targeting of brachyury transcription factor addiction in chordoma 1.46
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 1.45
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 1.45
RNA-Seq analysis of human colorectal cancer with liver metastasis 1.43
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 1.41
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 1.39
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 1.36
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 1.35
Select correlative genes involved in pathogenesis of idiopathic interstitial pneumonia by high-throughput sequencing analysis 1.31
Gene profiling of human adult and pediatric liver cancer cells 1.31
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 1.3
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 1.3
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 1.27
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 1.26
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 1.26
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 1.26
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 1.26
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 1.25
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 1.24
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 1.24
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 1.23
Gene expression profile in breast cancer cells 1.23
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 1.23
Gene expression analysis of human adenomas. 1.19
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 1.18
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 1.12
Gene expression analysis of human liver progenitor-like cells in culture 1.11
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 1.09
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 1.09
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 1.08
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 1.08
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 1.05
Transcriptome analysis of virus infected tissues 1.04
RNA-seq of primary patient AML samples 1.02
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 1.02
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 0.98
Copper Regulation of HIF-1 Transcription Activity 0.98
ML29755 RNA-seq data 0.97
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 0.94
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 0.9
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 0.84
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 0.81
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 0.81
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 0.8
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 0.78
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 0.77
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 0.77
Transcriptomic analysis of ERR alpha orphan nuclear receptor 0.75
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 0.74
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 0.72
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 0.65
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 0.64
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 0.61
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 0.59
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 0.56
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.52
Identification of expressed and conserved human non-coding RNAs 0.52
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 0.51
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 0.5
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 0.49
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 0.46
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 0.44
RNA-sequencing 0.43
RNA-Seq of Breast and Ovarian Cancer Cell Lines 0.43
Gene expression of thyroid cancer cell lines 0.43
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 0.4
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 0.4
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.38
The gene expression profiles of gallbladder cancer 0.38
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 0.36
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 0.35
Regulation of hypoxia-inducible factor activity by ZMYND8 0.33
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 0.32
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 0.3
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.25
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.23
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 0.22
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 0.17
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 0.16
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.16
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.16
RNA seq analysis of human Fetal and adult derived Enterospheres 0.16
RNA sequencing analysis of selumetinib-resistant CRC cells lines 0.14
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.09
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.07
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 0.05
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.04
Fibroblasts in cholesteatoma activate osteoclasts. 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation